Form 13-F position report

BETTER THERAPEUTICS INC COM (D

Reported by STATE STREET CORPORATION

BTTX CUSIP 08773T104 Manager CIK 0000093751

Reported 0 shares, down 58,600 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q1 2024
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 10 Through Q1 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 62000
2022-03-31 0
2022-06-30 71000
2022-09-30 80000
2022-12-31 50624
2023-03-31 32906
2023-06-30 48816
2023-09-30 22608
2023-12-31 11427
2024-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

10 quarters
Quarterly reported position history for BETTER THERAPEUTICS INC COM (D held by STATE STREET CORPORATION.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2024 Reduced 0 -58,600 (-100.0%) 0 $0 2024-05-15
Q4 2023 Unchanged 58,600 0 (0.0%) < 0.01% $11,427 2024-02-14
Q3 2023 Added 58,600 +13,400 (29.6%) < 0.01% $22,608 2023-11-14
Q2 2023 Unchanged 45,200 0 (0.0%) < 0.01% $48,816 2023-08-14
Q1 2023 Unchanged 45,200 0 (0.0%) < 0.01% $32,906 2023-05-15
Q4 2022 Unchanged 45,200 0 (0.0%) < 0.01% $50,624 2023-02-14
Q3 2022 Unchanged 45,200 0 (0.0%) < 0.01% $80,000 2022-11-15
Q2 2022 New 45,200 +45,200 (0.0%) < 0.01% $71,000 2022-08-15
Q1 2022 Reduced 0 -13,327 (-100.0%) 0 $0 2022-05-16
Q4 2021 New 13,327 +13,327 (0.0%) < 0.01% $62,000 2022-02-14

Who else reported the position

23 managers reported BETTER THERAPEUTICS INC COM (D for Q1 2024.

Managers reporting BETTER THERAPEUTICS INC COM (D in Q1 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Capital Investment Advisory Services LLC Unchanged 71,000 0 < 0.01% $994 3 qtrs
XTX Topco Ltd Added 32,670 +18,198 < 0.01% $457 2 qtrs
Aspire Private Capital LLC Unchanged 200 0 < 0.01% $3 8 qtrs
Bank of America Corporation Reduced 0 -216 0 $0 2 qtrs
GROUP ONE TRADING L P Reduced 0 -10,351 0 $0 6 qtrs
AMERIPRISE FINANCIAL INC Reduced 0 -15,000 0 $0 7 qtrs
ROYAL BANK OF CANADA Reduced 0 -584 0 $0 4 qtrs
SUSQUEHANNA INTERNATIONAL GROUP LLP Reduced 0 -38,057 0 $0 2 qtrs
WELLS FARGO & COMPANY MN Reduced 0 -179 0 $0 10 qtrs
MMCAP International Inc SPC Reduced 0 -356,270 0 $0 3 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2024
Filed
May 15, 2024
Filing type
13F-HR
Position type
COMMON STOCK

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.